HCMT
GCVRZ

Highland Capital Management (Tennessee)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300
Closed – – 686
2015
Q3 		$0 Hold
300
– – ﹤0.01% 727
2015
Q2 		$0 Buy
+300
New +$208 ﹤0.01% 686

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Highland Capital Management (Tennessee)'s GCVRZ Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 300 shares.

Highland Capital Management (Tennessee) first reported a position in GCVRZ in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 300 Sanofi Contingent Value Rights shares in Q4 2015.
  • Highland Capital Management (Tennessee) first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Sanofi Contingent Value Rights position peaked at $0 in Q3 2015.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.